Wilmot Cancer Center Honors Renowned Bladder Cancer Expert
The James P. Wilmot Cancer Center today honored Urology Chair Edward M. Messing, M.D., F.A.C.S., for his outstanding work in advancing bladder cancer research. He received The Davey Memorial Award for Outstanding Cancer Research, the Wilmot Cancer Center’s highest honor for researchers.
“He has a long history of important contributions to the treatment of people with bladder cancer. He is clearly one of the world leaders in this area and the caliber of his work is outstanding and we’re proud to recognize him with this prestigious award,” said Richard I. Fisher, M.D., director of the Wilmot Cancer Center.
Messing is a renowned expert in the diagnosis and treatment of cancers of the bladder, prostate, kidney and other genitourinary organs. He leads extensive research in the basic biology of bladder and prostate cancers.
His investigations have centered on the effectiveness of hormone therapies to treat prostate cancer and certain nutrients, such as Vitamin E, to prevent it, new ways to detect bladder cancer earlier and new drug treatments to prevent its recurrence. He also studies the roles of sex hormones, their receptors and physician and patient behaviors in explaining the differences between the genders in bladder cancer incidence and mortality.
Messing is the Winfield W. Scott Professor and chairman of the Department of Urology and professor of Oncology and Pathology at the University of Rochester School of Medicine and Dentistry. He brings vast clinical and research expertise to all facets of the department, with the main goal of improving the treatment of genitourinary cancers for patients.
Messing earned his M.D. degree from New York University. He completed surgical training at NYU-Bellevue Hospital and a urology residency at Stanford University. He completed a fellowship in urologic oncology at University of California at Los Angeles in 1982.
He was director of the Urologic Oncology Program at the University of Wisconsin from 1982-1995, before joining the University of Rochester Medical Center.
The Wilmot Cancer Center is the leader in cancer care and research in the Rochester and Finger Lakes region. The team of 400 doctors, nurses, scientists and staff are committed to finding cures for cancer.
Author
